Neoplasms of the lung
Leora Horn , W Pao , DH Johnson ,
Harrison's principles of internal medicine 18 743 -743
119
2012
Continued Afatinib (A) With the Addition of Cetuximab (C) After Progression on Afatinib in Patients With Acquired Resistance (AR) to Gefitinib (G) or Erlotinib (E): Metastatic Non-Small Cell Lung Cancer
L Horn , S Gettinger , R Camidge , E Smit
International Journal of Radiation Oncology, Biology, Physics 90 ( 5) S39 -S40
3
2014
Synopses of Research Articles
W Pao , TY Wang , GJ Riely , VA Miller
Activity and tolerability of afatinib (BIBW 2992) and cetuximab in NSCLC patients with acquired resistance to erlotinib or gefitinib
YY Janjigian , HJ Groen , L Horn , EF Smit
Journal of Clinical Oncology 29 7525 -7525
132
2011
ACTIVITY OF AFATINIB/CETUXIMAB IN PATIENTS (PTS) WITH EGFR MUTANT NON-SMALL CELL LUNG CANCER (NSCLC) AND ACQUIRED RESISTANCE (AR) TO EGFR INHIBITORS
YY Janjigian , EF Smit , L Horn , HJM Groen
Annals of Oncology 23 401 -401
49
2012
Afatinib (A) plus cetuximab (C) in the treatment of patients (pts) with NSCLC: The story so far
E Smit , J-C Soria , YY Janjigian , HJM Groen
Annals of Oncology 28
1
2017
Paradigms for the development of transformative medicines—lessons from the EGFR story
W Pao , YA Nagel
Annals of Oncology 33 ( 5) 556 -560
2
2022
Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms tumors (vol 11, pg 405, 2017)
D Polosukhina , HD Love , H Correa , Z Su
MOLECULAR ONCOLOGY 13 ( 4) 978 -978
1
2019
Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types
Joshua N Sampson , William A Wheeler , Meredith Yeager , Orestis Panagiotou
WOS
162
2015
Comprehensive genomic characterization of squamous cell lung cancers
Peter S Hammerman , Michael S Lawrence , Douglas Voet , Rui Jing
Nature 489 ( 7417) 519 -519
3,666
2012
Oral iron supplementation after blood donation: a randomized clinical trial
Joseph E Kiss , Donald Brambilla , Simone A Glynn , Alan E Mast
Jama 313 ( 6) 575 -583
153
2015
Erlotinib in lung cancer.
Chadi Nabhan , Jacob D Bitran ,
The New England journal of medicine 353 ( 16) 1739 -41; author reply 1739
34
2005
Association of KRAS aud EGFR mutations with survival in patients with advanced lung adeoearci-nomas
L Melissa , CS Sima , J Chaft ,
Cancer 119 ( 2) 356 -362
2
2013
Nicht kleinzelliges Lungenkarzinom–doppelte Resistenzentwicklung
M Moeller , U Siebolts , C Wickenhauser , W Schuette
Pneumologie 72 ( 07) 503 -506
2018